Клиника и терапия биполярной депрессии
Скачать 0.53 Mb.
|
ЛИТЕРАТУРА 1. Александров А. А. Принципы терапии биполярной депрессии //Вестник БПА, №12 , 2007, с. 45-55. 2. Костюкова Е.Г., Мосолов С.Н. Современные подходы к диагностике, лечению и профилактике депрессии при биполярном расстройстве // Социальная и клиническая психиатрия, 2003, №4, с. 106-114. 3. Мосолов С.Н., Костюкова Е.Г., Кузавкова М.В. Биполярное аффективное расстройство: диагностика и терапия / Под ред. С.Н. Мосолова. - М.: МЕДпресс-информ, 2008 , с. 15. 4. Мосолов С.Н. Клиническое применение современных антидепрессантов. - СПб.: Медицинское информационное агентство, 1995. - 566 с. 5. Ahlfors U.G., Baastrup PC, Dencker S.J. et al. Neuroleptic-in-duced extrapyramidal side effects in bipolar and schizophrenic patients/Ahlfors U.G. //Acta Psychiatr. Scand. - 1981. Sept. Vol. 64, No. 3, p. 226-237. 6. Ahrens В., Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? // Pharmacopsychiatry. - 2001; 34(4): 132-136. 7. Akiskal H.S., Akiskal K. Re-assesing the prevalence of bipolar disorders: Clinical significance and artistic creativity//Psychiatr. Psy-chobiol. - 1988. Vol. 3. P. 19-36. 8. Akiskal H.S., Pinto Q. The evolving bipolar spectrum prototypes I, II, III and IV. The Psychiatric clinics of North America. Bipolarity:Beyong classic mania, ed. H. Akiskal. Saunders Co. Philadelphia, 1999, Vol. 22, No. 3, Sept., P. 517-535. 9. Altshuler L.L., Post R.M., Levehch G.S., Mikalauskas K., Rosoff A., Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited //Am. J. Psychiatry. - 1995. 152 : 1130-1138. 10. Altshuler L, Kiriakos L, Calcagno J. et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1 -year risk for relapse of bipolar depression: a retrospective chart review//J. Clin. Psychiatry. - 2001. 62 : 612-616. 11. Altshuler L, Suppes Т., Black D. et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up // Am. J. Psychiatry. -2003; 160:1252-1262. 12. Amsterdam J., Shults J. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression // J. Affect Disord. - 2005. 87: 121-130 13. Amsterdam J.D., Shults J. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study//J. Clin. Psychopharmacol. -2008. April, 28 (2):171-81. 14. Angst J. The course of affective disorders : II. Typology of bipolar manic-depressive illness // Archiv fur Psychiatrie und Nervenk-rankheiten, 1978, 226, 65-73. 15. A.P.A. Practice guideline forthenotreatment of patients with bipolar disorder (revision) //Am. J. Psychiatry. - 2002. 159: 1-50. 16. Baldessarini R.J. etal. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders // Psychiatr Serv. 2007, 58(1). 17. BallengerJ.C, PostR.M. Carbamazepine in manic-depressive illness: A new treatment // Am. J. Psychiatry. - 1980. Vol. 137, P. 782-790. 18. BallengerJ.C. The clinical use of carbamazepine in affective disorders//J. Clin. Psychiatry. - 1988. 49 (Suppl.): 13-21. 19. Bebbington P., Ramana R. The epidemiology of bipolar affective disorder//Soc. Psychiatry Psychiatr. Epidemiol. - 1995. Vol. 30, P. 279-92. 20. Benazzi F. Prevalence of bipolarll disorder in outpatient depression. A203-case study in private practice // J. Affect. Disord. -1997. Vol.43, P. 163-166. 21. Bowden C.L. Lamotrigine in the treatment of bipolar disorder // Expert Opin Pharmacother 2002, 3: 1513-19. 22. CalabreseJ.R., Deluccni G.A. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder//Am. J. Psychiatry. - 1990. Vol.147, P. 431-434. 23. CalabreseJ.R., Bowden C, FieveR. etal. Adouble-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression//J. Clin. Psychiatry. - 1999, 60:79-88. 24. Calabrese J. R., Macfadden W., McCoy R., Minkwitz M., Wilson E., Kuklen J. Double-blind placebo-controlled study of quetiapine in bipolar depression //АРА Annual Meeting, New YORK, Abstracts NR 2004. 25. Calabrese J.R., Keck P.E., Macfadden l/l/. et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression//Am. J. Psychiatry- 2005. 162: 1351-1360. 26. Cassano G.B., Akiskal H.S., Savino M. et al. Proposed Subtypes of bipolar 2 and related disorders:with hypomanic episodes (or cyclothymia) and with hyperthymic temperament//J. Affect Disord. -1992. Vol.11, P. 205-206. 27. Cassano G.B., Jori M.C., and AMIMAJOR Group. Efficasy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: A randomized, double-blind, parallel group study. Int Clin Psychopharmacol. - 2002. 17: 27-32. 284. 28. Catapano-Friedman L. Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis//J. Child Adol Psychopharmacol. -2001;11:205-206. 29. Compton M.T., Nemeroff C.B. The treatment of bipolar depression //J. Clin. Psychiatry. - 2000. Vol. 61, No. 9, P. 57-67. 30. Corapcioglu A., Kocabasoglu N., Yargic I. A randomized, single-blind, multicenter prospective trial comparing the efficasy and sefety of paroxetine with or wiyhout quetiapine therapy on depression associated with anxiety. - 2003. 31. Coryell W., Scheftner W., Keller M. et al. The enduring psychosocial consequences of mania and depression // Am. J. Psychiatry. - 1993. Vol. 150, P. 720-727. 32. Coryoll W., EndicottJ., MaserJ.D. etal. Long term stability of polarity distinctions in the affective disorders // Am. J. Psychiatry. -1995. Vol. 152,385-390. 33. Daly J.J., PmdicJ., Devanand D.P. etal. ЕСТ in bipolar and unipolar depression: differences in speed of response // Bipolar Disord. -2001. 3(2): 95-104. 34. Daws L.L., Bartolucci A., Petty F. Divalproex in the treatment of bi- polar depression: a placebo-controlled study // J. Affect. Disord. - 2005.85(3):259-66. 35. DoreeJ.P, Tourjman V., Kunicki S., Desrosiers J'., Vanise C, Elie R., Lew V.A. Comparison of quetiaoine versus lithium treatment resistant depression. АРА Annual Meeting, New YORK, Abstracts NR. - 2004, 273. 36. Ehnvall A., Agren H. Patterns of sensitization in the course of affective illness / A life-charting study of treatment-refractory depressed patients//J. Affect. Disord. - 2002. Vol.70, P. 67-75. 37. Fountouiakis K.N., Vieta E., Sanchez-Moreno J. et al. Treatment guidelines for bipolar disorder: a critical review //J. Affect Disord. -2005.86(1): 1-10. 38. Frye M., Ketter T.A., Kimbrell T.A. etal. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders//J. Clin. Psychopharmacol. 2000. 20 : 607-614. 39. Gao K, Gajwani P., Elhaj O., Calabrese J.R. Typical and atypical antipsychotics in bipolar depression //J. Clin. Psychiatry. - 2005. Nov., 66 (11): 1376-1385. 40. Gelenberg A.J., Kane J.M., Keller M.B. Comparison of standart and low serum levels of lithium for maintance treatment of bipolar disorders//N. Engl. J. Med. - 1989. P. 1489-1493. 41. Gijsman H. J. etal. Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials//Am. J. Psychiatry. - 2004. 161 :1537-1547. 42. Goodwin F.K., Jamison К Manic-Depressive Illness. - New York: Oxford University Press, 1990. 43. Goldberg J. Spontaneons depression versus biphasic cycling // Am. J. Psychiatry.-2001. Vol.158, P. 124-126. 44. Grunze et al. World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression //World J. Biol. Psychiatry. -(2002)3, 115-124. 45. Handtouch E. G, Akiskal H. S., Lancrenon S. et al. Systematic clinical methodology for validating bipolar II disorder//J. Affect. Disord. -1998. Vol. 50, P. 163-173. 46. Hirschfeld R.M.A., Lewis L., VornikL.A. Perceptions and impact of bipolar disorder: How far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder // J. Clin. Psychiatry. - 2003. 64: 161-74. 47. JuddL.L., AkiskalH.S., SchettlerP.J., EndicottJ., MaserJ., Solomon D.A., LeonA.C, Rice J.A., Keller M.B. The long-term natural history of the weekly symptomatic status of bipolar I disorder // Arch. Gen. Psychiatry. - 2002, Jun. No. 59 (6), P. 530-537. 48. Kalinin V.V. Suicidally and Antiepileptic Drugs: Is there a Link? Drug Saf. - 2007. 30 (2) : 123-42. 49. Keck RE., McElroy S.L. Divalproex in the Treatmentof Bipolar Disorder// Psychopharmacology. - Bulletin 2003. 37 (Suppl. 2): 67-73. 50. Keller M.B., Lavori P.W., Coryell W. etal. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness // JAMA. - 1986. Vol. 255, P. 3138-3142. 51. Ketter T.A., Calabrese J.R. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature // J. Clin. Psychiatry. - 2002. 63 : 146-151. 52. Kravitz H.M., Fawcett J. Carbamazepine in the treatment of affective disorders//Med. Sci. Res. - 1987, No. 15, P. 1-8. 53. Kupfer D.J., Frank E., Grochocinski V.J. et al. Stabilization in the treatment of mania, depression and mixed states // Acta Neuropsychiatries. - 2000. No. 12, P. 110-114. 54. Lambert P.A. Acute and prophylactic therapies of patients with affective disorders using valpromide (dypropylaetamide). In: Anticonvulsants in affective disorders Edited by H.E. Emrich, T Oku-ma, A.A .Muller. Elsevier Science Publishers. - Amsterdam, Ox-ford, Princeton, 1984. 55. Lish J.D., Dime-Meenan S., WhybrowRC. etal. The national De-piessivo and Manic-Depressive Association (DMDA) survey of bi-polai members// J. Affect. Disord. - 1994. Vol. 31, No. 4, P. 281-;"M 56. Mnclnddon W., Calabrese J., McCoy R., Minkwitz R., Wilson £., Mullen J. Double-blind, placebo-controlled study of quetiapine In bipolar I depression. Poster presented at the XXIVth Collegium Internationale Nouro-Psychopharmacologicum (CINP) Congress, June 20-24, 2004, Paris, France. 57. Malhi G.S., Vieta E. Topics in contemporary psychiatric practice diagnosing bipolar disorder // Int. J. Psych. Clin. Pract. - 2001. Vol. 5, No. 3, P. 223-224. 58. Malhi G.S., Mitchell P.В., Salim S. Bipolar depression: management options // CNS Drugs. - 2003. 17(1): 9-25. 59. Mclntyre R.S., Mancini D.A., McCann S. etal. Topiramate versus bupropion SR when added to mood-stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study // Bipolar Disord., 2002, Vol. 4, No. 3, P. 207-213. 60. Medical Practice Project. A state-of-the-science report for office of Assistant Secretary for the US Department of Health, Education Welfare. - Baltimore, 1979. 61. Miller-Siecheneder F., Miller M.J., Hillert A., Szegedu A., Wetzel H., Benkert O. Risperidone versus haloperidol in the treatment of patients with a combined psychotic and depressive syndrome //J. Clin. Psychopharmacol.-1998. 18: 111-120. 62. Montgomery S.A. The advantages of paroxetine in different subgroups of depression // Int. Clin. Psychopharmacol. - 1992. Vol. 6, (suppl 4), P. 91-100. 63. Mitchell P.B., Wilhelm K, Parker G. et al. The clinical featuresof bipolar depression: a comparison with matched major depressive disorder patients // J. Clin. Psychiatry. - 2001. P. 62. 64. Mitchell P. В., BallJ.R., Best J. A. etal. The management of bipolar disorder in general practice // MJA. - 2006. 184 (11): 566-70. 65. Nemeroff С et al. Pharmacotherary of depression and mixed states in bipolar disorder // J. Affect. Disord. - 2000. Sept., V. 59, Suppl. 1, P. 39-56. 66. Nemeroff С. В. etal. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression//Am. J. Psychiatry. - (2001) 158 : 906-912. 67. Neumann J., Siedel K., Wunderlich H. Anticonvulsants in affective disorders/Ed. byH.M. Emrich etal. Amsterdam Oxford Princeton: Exerpta Medica, 1984. P. 1160-1166. 68. Perris С A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses // Acta. Psychiatr. Scand. - 1966. Vol. 42, P. 1-188. 69. PostR.M. Transduction of psychological stress into the neurobiology of recurrent affective disorder // Am. J. Psychiatry. - 1992. Vol.149, P. 999-1010. 70. Posf P.M. etal. Alternative approaches to refractory depression in bipolar illness //Depress Anxiety. - 1997. 5 : 175-189. 71. Post P.M., Unde T.W., Poy-Byrne P.P. etal. Antidepressant effects of carbamazepine//Am. J. Psychiatry. - 1986. 143 : 29-34. 72. Post R. M., Denicoff K. D., Leverich G. S., Altshuler L. L et al. Presentation of depression in bipolar illness. Clinical neuroscience Research 2. - 2002. P. 142-157. 73. Post P.M., Leverich G.R., Nolen W.A. et al. A reevaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network // CNS Spectrum, 2003. Vol. 8, No. 12 (Suppl. 4), P. 1-15. 74. Post R.M. Recent data from the Stanley Foundation bipolar treatment outcome network // CNS Spectrum. - 2004. Vol. 9, No.1 (Suppl. 1). P. 1-24. 75. Post R.M., Altshuler L.L., Leverich G.S., Frye M.A., Nolen W.A., Kupka R.W., Suppes T, McElroy S., Keck P.E., Denicoff K.D., Grunze H., Walden J., Kitchen CM., MintzJ. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline//Br. J. Psychiatry. -2006. Aug., 189: 124-31. 76. Prien R.F., Klett C.J., Caffey E.M. Lithium carbonate and imi-pramine in the prevention of affective episodes //Arch. Gen. Psychiatry. - 1973. Vol. 29, P. 420-425. 77. Prudic J., Sackeim H., Devanand D.P Medication resistance and clinical response to ЕСТ//Psychiatry Res. - 1990. 31 : 287-96. 78. RapaportM.N., Canuso CM., Rouillon F., LeblancJ., Young A.H., Loosher A., Bossie C, Turkoz I., Gharabawi G. Results from the augmentation with risperidone in resistant depression trial //АРА Annual Meeting, New York, Abstracts NR. - 2004. 301 p. 79. Roy-Byme P., Post R.M., Uhde T.W. etal. The longitudinal course ol mcuimnl affective illness: life chart data from research patients al Hi.; NIMH//Acta. Psychiatr. Scand. - 1985. Vol. 317, P. 1-34. 80. Sachs G.S., Later В., Stoll A.L., Banou M., Triboult A.B., Tohen M., Honcnhntim J.F. A double-blind trial of bupropion versus desipramine for bipolar depression // J. Clin. Psychiatry. - 1994. Vol. 55, P. 391-393. 81. Sachs G.S., Ghaemi S.N. Safety and efficacy of risperidone versus placebo in combination with lithium or valproate in the treatment phase of bipolar disorder // Int. J. Neuropsychopharmacol. -2000, 3 (suppl. 1):S. 143, (Abstract). 82. Sachs G.S., Altshuler L.L., Ketter T.A. etal. Divalproex versus placebo for the treatment of bipolar depression // American College of Neuropsychopharmacology. Abstracts. 2001. 83. Sachs G.S. STEP-BD Update: What have we learned, in International Bipolar Disorder. - 2003. Pittsburgh, PA: Western Psychiatric Institute and Clinic, UPMC Health System. 84. Sachs G. Managing bipolar affective disorder. - London, Science Press.-2004. 146 p. 85. Sachs G. Antidepressants may be useless in bipolar depression. 21st ECNP Congress, Barselona, Spain, 30 Aug.-3 Sept., 2008. 86. Small J.G. Anticonvulsants in affective disorders // Psychophar-macol Bull. - 1990. 26 : 25-36. 87. Stahl S.M., Shelton R.C. Risperidone with and without paroxetine compared to paroxetine alone for bipolar depression // ACNP Annual Meeting, Waikoloa, Hawaii, Abstracts. 2001, 352 p. 88. Stromgren L., Bolloi S. Carbamazepine in treatment and prophylaxis of manic-depressive disorder// Psychiat. Dev. - 1985. Vol. 4, P. 349-367. 89. Suppes Т., Kelly D.I., Perla J.M. Challenges in the management of bipolar depression // J. Clin. Psychiatry. - 2005. 66 (Suppl. 5): 11-16. 90. The Expert Consensus Guideline Series. Treatment of bipolar disorder. Steering Committee: Allen Frances, John P. Docherty, David A. Kahn // The Journal of Clinical Psychiatry. - 1996. V 57, Suppl. 12A. 91. Tohen M., Vieta E., Calabiose J.R. etal. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar depression. Arch. Gen. Psychiatry. - 2003. 60: 1079-1088. 92. Tondo L., Baldessarini R.J., Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I u II bipolar disorders // Brit. J. Psychiatry. - 2001. Vol. 178. (Suppl.41), P. 184-190. 93. Tondo L, Baldessarini R.J. Rapid cycling in women and men with bipolar manic-depressive disorders//Am. J. Psychiatry. - 1998. 155:1434-1436. 94. Truman E.etal. Retrospective review of the bipolar disorder course in community // Poster at АРА annual meeting San Francisco, May 17-22, 2003. Abstract 251. 95. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy// N. Engl. J. Med. - 2008. 358 : 252-260. 96. Vieta E. Managing Bipolar Disorder in Clinical Practice // Published by Current medicine group Ltd, Porters South, London, UK, 2006. 97. Wehr ТА., Goodwin F.K. Can antidepressants cause mania and worsen the course of affective illness?//Am. J. Psychiatry*) 1987. Vol. 144, P. 1403-1411. 98. Weisler R. H., Calabrese J. R., Thase M. E., Arvekvist R., Stening G., Paulsson В., Suppes T. Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. 99. Westenberg H.G.M., Denis D., Klompmakers A.A. Synergistic effects of quetiapine in combination with fluvoxamine on dophamine release in rat prefrontal cortex (abstract) // Eur. Neuropsychop-harmacology. - 2003. Vol. 3, (Suppl.4), P. 462. 100. Winsberg M.E., DeGolia S.G., Strong C.M. etal. Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression // J. Affect. Disord.- 2001. 67 (1 -3): 207-212. 101. Zomberg G.L., Pope H.G. Treatment of depression in bipolar disorder: new directions for research // J. Clin. Psychopharmacol. -1993. Vol. 13, P. 397-408. _________________________________________________________________________________________ C.H. Мосолов, Е.Г. Костюкова, А.В. Ушкалова Клиника и терапия биполярной депрессии ООО «AMА-ПРЕСС», 1111 16,1. Москва, Энергетический пр., д. 3, стр.1 |
Похожие:
 | Психотерапия: теория и практика Бек А., Раш А., Шо Б., Эмери Г. Когнитивная терапия депрессии. 2003, 304с., Питер |  | Шизофрения и расстройства шизофренического спектра, коморбидные сердечно-сосудистой... Автор: Жигунова Г. В., кандидат философских наук, доцент кафедры «социальных наук» |
| Движется ли мировая экономика к новой Великой депрессии? Великой депрессии. С наступлением октября в мировой экономике отчетливо обозначился поворот к худшему: значительно замедлились темпы... | | Психические расстройства у детей, впервые госпитализированных по поводу гемобластозов Охватывает основные характеристики депрессии и учитывает психологические особенности данной возрастной группы. Опросник cdi предназначен... |
| Учебно-методический комплекс по курсу «Зависимости: клиника, психология, лечение» Г. В. Старшенбаум. «Зависимости: клиника, психология, лечение». – М.: Ноу впо «Институт психоанализа», 28 с | | Лучевая терапия юношеской ангиофибромы основания черепа 14. 00. 19.... Муниципальное автономное общеобразовательное учреждение «Панковская средняя общеобразовательная школа» |
| Рабочая программа по Терапии цикла профессиональной переподготовки... Программа составлена в соответствии с требованиями фгос впо к содержанию дополнительных профессиональных образовательных программ,... | | Реферат по курсу: «Арт-терапия» Эволюция понятия «арт-терапия»отображает процессы обособления трех самостоятельных направлений: медицинского, социального, педагогического.... |
| Аннотация рабочей программы учебной дисциплины "Госпитальная терапия,... Целями освоения дисциплины (модуля) «Госпитальная терапия, эндокринология» являются | | Программа подготовки клинических ординаторов по специальности «Терапия»... Программа составлена на основании Государственного стандарта послевузовской профессиональной подготовки специалистов с высшим медицинским... |
| «структурные особенности соматовегетативных нарушений при разных типах депрессии» | | «Клинические формы туберкулеза органов дыхания. Классификация. Клиника и ди агностика» Тема занятия: «Клинические формы туберкулеза органов дыхания. Классификация. Клиника и диагностика» |
| Рабочая программа По специальности «Терапия» для постдипломной подготовки врачей-интернов Типового учебного плана и программы одногодичной специализации (интернатуры) выпускников медицинских факультетов по специальности... | | «Влияние эсциталопрама на динамику соматовегетативных расстройств... |
| Рабочая программа по элективной дисциплине «поликлиническая терапия»... «Поликлиническая терапия» составлена на основании Программы по поликлинической терапии для студентов лечебных факультетов высших... | | Как избавиться от тревоги, депрессии и раздражительности андрей Владимирович курпатов Программа развития научно-исследовательского и экспедиционного флота Росгидромета на 2010 – 2012 годы |
